Market turbulence brought on by COVID-19 has contributed to disruptions across all facets of life sciences organizations, including the pressure to rapidly perform, transform, and respond, all at the same time. Staying competitive while meeting patient demands requires life sciences organizations to find new ways of working.
EY has identified common trends and technology capabilities required in the life sciences industry in order to respond to disruption. The EY Intelligent Life Sciences offering and industry knowledge can support your company to address these changes on SAP offerings. Here are a few data points from industry resources:
Our value-led approach is specifically designed for the life sciences industry and tailored to the client’s business needs, ambitions, with focus on:
This paves the path forward for each organization, whether they are embarking upon complete transformation, upgrading a previous rollout or somewhere in between. The EY approach has the ability to track business benefits from kick-off to go-live and builds enterprise-wide buy-in for change.
Our Intelligent Transformation Platform (ITP), which includes a complete suite of tools that drive a value-focused services, using automation to streamline and fast track system build, testing and data migration helps in accelerating the delivery.
Our offering, based on SAP best practices, features all key processes across finance, manufacturing, quality and supply chain. It also includes industry-specific EY differentiators for cell and gene therapy.
With this approach, we are engaging the business throughout the project to achieve successful, sustainable change.
We are taking a whole-of-business approach — from tax, supply chain, climate change and sustainability — to unlock greater business benefits from the transformation. The typical goal is to harmonize and simplify processes and systems in order to help maximize business benefits and lowered total cost of ownership (TCO) with minimal business disruption.
To help clients use the technologies across the industry value chain while preparing their businesses for the future, EY teams have developed a detailed pre-built, life sciences-specific SAP offering augmented with EY differentiators called EY SAP Intelligent Life Sciences. Based on the latest version of SAP S/4HANA®, this offering covers key processes in an offering leveraging SAP leading practices and latest products, such as SAP Commerce Cloud, SAP Integrated Business Planning® (IBP), SAP Ariba®, SAP Advanced Track and Trace for Pharmaceuticals® (ATTP) and SAP Government, Risk and Compliance® (GRC).
The EY Intelligent Life Sciences offering is based on the EY Life Sciences Process Architecture (LiSPA). It reflects market demands and their impacts on sourcing and procurement decisions and operations with a focus on quality. It also contains processes mapped to SAP transactions or SAP Fiori® apps, key performance indicators, and controls and integrated via ARIS with SAP Offering Manager®.
Our pre-built SAP offering for life sciences is complemented by an extensive suite of industry and tax innovations to help deliver extra value to the business.